SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,000 | -79.7% | 12,222 | -80.4% | 0.00% | -100.0% |
| Q4 2021 | $79,000 | -44.4% | 62,257 | -4.5% | 0.00% | -50.0% |
| Q3 2021 | $142,000 | -42.0% | 65,157 | -0.5% | 0.00% | -33.3% |
| Q2 2021 | $245,000 | +26.9% | 65,457 | +10.5% | 0.00% | +50.0% |
| Q1 2021 | $193,000 | -2.5% | 59,217 | +2.1% | 0.00% | -33.3% |
| Q4 2020 | $198,000 | -17.5% | 58,017 | -1.6% | 0.00% | -25.0% |
| Q3 2020 | $240,000 | +55.8% | 58,934 | +29.7% | 0.00% | +100.0% |
| Q2 2020 | $154,000 | +45.3% | 45,434 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $106,000 | -35.8% | 45,434 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $165,000 | -53.4% | 45,434 | +6.6% | 0.00% | -60.0% |
| Q3 2019 | $354,000 | -1.9% | 42,634 | +1.7% | 0.01% | 0.0% |
| Q2 2019 | $361,000 | -14.3% | 41,934 | +6.6% | 0.01% | -16.7% |
| Q1 2019 | $421,000 | +24.6% | 39,337 | +1.8% | 0.01% | +20.0% |
| Q4 2018 | $338,000 | – | 38,626 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |